How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022.
Saved in:
| Title: | How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022. |
|---|---|
| Authors: | Althaus T; Directorate of Health Affairs, Monaco, Monaco. talthaus@gouv.mc., Overton CE; Department of Mathematical Sciences, University of Liverpool, Liverpool, UK.; United Kingdom Health Security Agency, London, UK., Devaux I; World Health Organization Regional Office for Europe, Copenhagen, Denmark., House T; Department of Mathematics, University of Manchester, Manchester, UK., Lapouze A; Directorate of Health Affairs, Monaco, Monaco., Troel A; Digital Service Department, Monaco, Monaco., Vanzo B; Digital Service Department, Monaco, Monaco., Laroche M; Directorate of Health Affairs, Monaco, Monaco., Bordero A; Directorate of Health Affairs, Monaco, Monaco., Jorgensen P; World Health Organization Regional Office for Europe, Copenhagen, Denmark., Pebody R; World Health Organization Regional Office for Europe, Copenhagen, Denmark., Voiglio EJ; Directorate of Health Affairs, Monaco, Monaco. |
| Source: | BMC medicine [BMC Med] 2024 Jun 05; Vol. 22 (1), pp. 227. Date of Electronic Publication: 2024 Jun 05. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1741-7015 |
|---|---|
| DOI: | 10.1186/s12916-024-03444-6 |
